Authors


Jennifer McQuade, MD

Latest:

Nurses May Advise Patients on Immunotherapy to Increase Fiber Intake

An expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.


Ruta Rao, MD

Latest:

Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.


Chevon Rariy, MD

Latest:

Cancer Care More Accessible Thanks to Launch of Telehealth and In-Home Infusion programs

Chevon Rariy, MD, outlines patient eligibility criteria, and the alterations to the nurse patient relationship, as CTCA launches the novel Oncology Clinic at Home Program.


Sylvester Comprehensive Cancer Center

Latest:

Sylvester’s Sexual Health After Cancer Program Expands to Meet Needs of Women with Cancer

Kristin E. Rojas, M.D., FACS, FACOG, assistant professor of surgical oncology in the DeWitt Daughtry Department of Surgery and Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine, realized she had struck a chord with women being treated for cancer when she started the Menopause Urogenital Sexual Health and Intimacy Clinic (MUSIC).


Karolina Faysman, NP

Latest:

Why Step-Up Dose With Bispecific Antibodies?

Karolina Faysman, NP, explains how step-up dosing is used to reduce CRS and ICANS with bispecific antibodies in multiple myeloma.


Olivia West, MSN, RN, AG-ACNP-BC

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP

Latest:

Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT Care

Tia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.


Benjamin P. Saylor

Latest:

Darolutamide Combination May Delay Disease Progression in Metastatic Hormone-Sensitive Prostate Cancer

Adding darolutamide to androgen deprivation therapy and docetaxel delayed the progression from metastatic hormone-sensitive prostate cancer to metastatic castration-resistant disease.


Cherry Rudge, NP

Latest:

Final Thoughts and Hope for a Cure

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.


Janice Post-White, PhD, RN, FAAN

Latest:

Overcoming The Burden of Guilt as A Nurse

Janice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, discusses how she handled the guilt she felt following her son’s leukemia diagnosis.


Ranee Mehra, MD

Latest:

Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment Selection

Ranee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.


Susan Samson, MSN, FNP-C

Latest:

Advanced Practice Providers Are Uniquely Suited for Survivorship Care

Advanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.


Edgardo Santos, MD, FACP

Latest:

Unmet Needs and Future Directions in the Management of CIM

Martin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.


Russ Conroy

Latest:

Subcutaneous Daratumumab Reduces Smoldering Myeloma Progression

New AQUILA data show PFS improvement in patients with smoldering multiple myeloma who were treated with subcutaneous daratumumab vs active monitoring.


Melina Marmarelis MD (MM)

Latest:

Long-Term Care in ALK+ NSCLC

Panelists discuss how they approach long-term monitoring and follow-up care for patients who have ALK-positive+ patients disease to maintain optimal outcomes on stable therapy.


Hayley Feuchs, LMSW

Latest:

Opinion: Increasing Support and Awareness for AYAs With Cancer

AYA Cancer Awareness Month offers an opportunity for nurses to go further in supporting AYAs with cancer.


Joannie Clements

Latest:

Advancing CML Management Towards an Ideal Patient Journey

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.


Aaron T. Gerds, MD, MS

Latest:

Key Takeaways for Patients With Myelofibrosis

Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.


Krista Gomez, MSN, BSN, RN, FNP-C

Latest:

Colorectal Cancer Screening: Education, Advocacy, and Action

It is essential to continue to develop and incorporate educational strategies to increase screening for colorectal cancer in our communities.


Shari Mycek

Latest:

Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCL

Discrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.


Jordyn Sava

Latest:

Retifanlimab Lengthens Survival for Patients With Anal Cancer

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.


Kristin Barber, APRN, AOCNP, FNP-BC

Latest:

Oncology Drug Crash Course: Tucatinib and Trastuzumab for HER2+ CRC

Tucatinib was first approved by the FDA for the treatment of patients with HER2-positive advanced unresectable or metastatic breast cancer in combination with trastuzumab and capecitabine on April 17, 2020.


Joyce O’Shaughnessy, MD

Latest:

Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies

Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.


Lindsay Fischer

Latest:

T-Cell Engagers Take Center Stage in Large B-Cell Lymphoma

Bispecific antibodies that engage T cells are an effective treatment modality in relapsed/refractory disease and are an important new treatment for relapsed large B-cell lymphoma.


Julie McGuire RN, MSN

Latest:

Opinion: Now Is the Time to Optimize Electronic Health Record Systems

Buying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.


David Dingli, MD, PhD

Latest:

Closing Reflection: A Journey of Understanding and Resilience

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease management and improve quality of life while identifying opportunities to strengthen provider communication and access to resources.


Kristin M. Daly, MSN, ANP-BC, AOCNP

Latest:

Kristin Daly on the Difference Between Somatic and Germline Variants in Precision Oncology

Kristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.


Cleveland Clinic

Latest:

Cleveland Clinic Opens New Cancer Center in Abu Dhabi

The state-of-the-art facility represents the organization’s vision of global cancer care


Sharon Kauffman, PhD, RN, CNE, NPD-BC, OCN

Latest:

Oncology Drug Crash Course: Pirtobrutinib (Jaypirca)

Sharon Kauffman, PhD, RN, CNE, NPD-BC, OCN, provides an in-depth look at pirtobrutinib in a downloadable reference sheet.


Marie Garcia, RN, OCN

Latest:

Innovative Program Reduces Nurse Turnover and Fosters Development

The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.